DISCOVERY
Uncover breakthrough
innovations during the drug
discovery phase.
innovations during the drug
discovery phase.
Hannah Hapner Hogan is a Regulatory Affairs professional with experience in biotechnology, medical devices, and combination products. Throughout their career, they have supported regulatory strategy and submissions across the product development lifecycle, including FDA interactions and cross-functional program coordination. Her experience spans the development and execution of regulatory pathways across a variety of product types and stages, working closely with multidisciplinary teams to advance products.
Prior to transitioning to Regulatory Affairs, they conducted research in cancer biology and cellular metabolism, contributing to studies of biological mechanisms and disease processes.
Hannah holds a Master of Science in Cellular Metabolism from Washington State University and a Bachelor of Science in Biology from The Ohio State University.
